Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Exelixis
EXEL
$13.5B
| $35.5M | 0.05% |
1,464,418
-18,686
| -1% | -$497K |
|
477
International Bancshares
IBOC
$4.45B
| $35.5M | 0.05% |
884,685
+857,871
| +3,199% | +$31M |
|
478
UGI
UGI
$8.19B
| $35.5M | 0.05% |
756,937
+472,286
| +166% | +$23.1M |
|
479
Cemex
CX
$15.9B
| $35.5M | 0.05% |
3,905,240
+2,589,641
| +197% | +$24.6M |
|
|
AGN
480
DELISTED
Allergan plc
AGN
| $35.4M | 0.05% |
172,581
+41,972
| +32% | +$9.76M |
|
481
DaVita
DVA
$11.3B
| $35.4M | 0.05% |
595,498
-439,949
| -42% | -$26.5M |
|
482
Lincoln National
LNC
$8.11B
| $35.3M | 0.05% |
480,358
+49,712
| +12% | +$3.51M |
|
483
Sunstone Hotel Investors
SHO
$2.1B
| $35.2M | 0.05% |
2,192,029
-46,252
| -2% | -$735K |
|
|
KLXI
484
DELISTED
KLX Inc.
KLXI
| $35.2M | 0.05% |
787,863
-569,051
| -42% | -$24.2M |
|
485
The Greenbrier Companies
GBX
$1.43B
| $35.1M | 0.05% |
729,647
-37,207
| -5% | -$1.65M |
|
486
New Oriental
EDU
$8.97B
| $35.1M | 0.05% |
397,898
+113,555
| +40% | +$9.25M |
|
|
CY
487
DELISTED
Cypress Semiconductor
CY
| $35M | 0.05% |
2,332,374
+202,413
| +10% | +$2.83M |
|
|
B
488
Barrick Mining
B
$79.3B
| $35M | 0.05% |
2,174,537
+1,153,989
| +113% | +$19.3M |
|
|
ILG
489
DELISTED
ILG, Inc Common Stock
ILG
| $34.9M | 0.05% |
1,306,832
+296,107
| +29% | +$7.84M |
|
490
Infosys
INFY
$47.9B
| $34.9M | 0.05% |
+4,777,704
| New | +$36.2M |
|
|
HK
491
DELISTED
Halcon Resources Corporation
HK
| $34.8M | 0.05% |
5,114,021
+1,852,188
| +57% | +$11.6M |
|
492
Toro Company
TTC
$9.47B
| $34.7M | 0.05% |
559,384
+495,889
| +781% | +$33.2M |
|
|
VMW
493
DELISTED
VMware, Inc
VMW
| $34.7M | 0.05% |
317,703
-107,943
| -25% | -$10.7M |
|
494
CALL
EQT Corp
EQT
$33.6B
| $34.6M | 0.05% |
975,447
-91,850
| -9% | -$3.12M |
|
495
Southwest Gas
SWX
$6.49B
| $34.6M | 0.05% |
445,883
+72,916
| +20% | +$5.77M |
|
|
SYNT
496
DELISTED
Syntel Inc
SYNT
| $34.6M | 0.05% |
1,759,634
+410,456
| +30% | +$7.49M |
|
497
Boston Scientific
BSX
$71B
| $34.4M | 0.05% |
1,178,236
+65,626
| +6% | +$1.81M |
|
498
Motorola Solutions
MSI
$79.7B
| $34.4M | 0.05% |
404,911
-360,614
| -47% | -$31.6M |
|
|
IMPV
499
DELISTED
Imperva, Inc.
IMPV
| $34.3M | 0.05% |
790,481
+436,822
| +124% | +$19.9M |
|
|
AMED
500
DELISTED
Amedisys
AMED
| $34.3M | 0.05% |
612,689
+457,729
| +295% | +$24.2M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.